EDRH
ALXN

Edmond de Rothschild Holding’s Alexion Pharmaceuticals ALXN Stock Holding History

Edmond de Rothschild Holding’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-84
Closed -$23K – 686
2020
Q3 		$23K Buy
84
+30
+56% +$3.24K ﹤0.01% 559
2020
Q2 		$17K Sell
54
-418
-89% -$44.4K ﹤0.01% 557
2020
Q1 		$21K Hold
472
– – ﹤0.01% 509
2019
Q4 		$68K Buy
+472
New +$50.5K ﹤0.01% 456

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edmond de Rothschild Holding's ALXN Position: Q1 2021 in Review

Edmond de Rothschild Holding sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 350 shares — an estimated $55K sold.

Edmond de Rothschild Holding first reported a position in ALXN in Q4 2016 and held it in 10 quarters. The position peaked at $1.95M in Q3 2020. 753 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Edmond de Rothschild Holding reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 350 Alexion Pharmaceuticals shares in Q1 2021, an estimated $55K.
  • Edmond de Rothschild Holding first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 10 quarters.
  • Edmond de Rothschild Holding's Alexion Pharmaceuticals position peaked at $1.95M in Q3 2020.
  • 753 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Edmond de Rothschild Holding's 13F filing for Q1 2021, filed 17 May 2021.